Brokerages Set Chemed Corporation (NYSE:CHE) Price Target at $574.25

Chemed Corporation (NYSE:CHE) has been assigned an average recommendation of “Moderate Buy” from the six brokerages that are covering the company, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average 12 month target price among brokers that have updated their coverage on the stock in the last year is $574.25.

A number of brokerages have recently issued reports on CHE. Weiss Ratings reiterated a “hold (c-)” rating on shares of Chemed in a research report on Wednesday, October 8th. Royal Bank Of Canada decreased their price objective on shares of Chemed from $589.00 to $572.00 and set an “outperform” rating on the stock in a report on Monday, November 10th. Finally, Zacks Research raised shares of Chemed from a “strong sell” rating to a “hold” rating in a research note on Thursday, October 30th.

Insider Buying and Selling at Chemed

In other news, CEO Kevin J. Mcnamara sold 2,000 shares of Chemed stock in a transaction that occurred on Monday, November 24th. The stock was sold at an average price of $437.55, for a total value of $875,100.00. Following the sale, the chief executive officer directly owned 94,197 shares of the company’s stock, valued at $41,215,897.35. The trade was a 2.08% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. 3.29% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Chemed

Several institutional investors and hedge funds have recently added to or reduced their stakes in CHE. WCM Investment Management LLC raised its position in shares of Chemed by 3.8% in the third quarter. WCM Investment Management LLC now owns 661 shares of the company’s stock valued at $299,000 after buying an additional 24 shares during the last quarter. Eukles Asset Management raised its holdings in Chemed by 0.4% in the 3rd quarter. Eukles Asset Management now owns 6,031 shares of the company’s stock valued at $2,700,000 after acquiring an additional 24 shares during the last quarter. Cim LLC lifted its stake in Chemed by 1.1% in the 3rd quarter. Cim LLC now owns 2,139 shares of the company’s stock worth $958,000 after purchasing an additional 24 shares in the last quarter. Atria Investments Inc lifted its stake in Chemed by 0.6% in the 2nd quarter. Atria Investments Inc now owns 4,259 shares of the company’s stock worth $2,074,000 after purchasing an additional 25 shares in the last quarter. Finally, Cetera Investment Advisers boosted its holdings in shares of Chemed by 1.5% during the 2nd quarter. Cetera Investment Advisers now owns 1,740 shares of the company’s stock worth $847,000 after purchasing an additional 25 shares during the last quarter. Institutional investors and hedge funds own 95.85% of the company’s stock.

Chemed Stock Up 0.6%

CHE stock opened at $448.94 on Friday. Chemed has a 52-week low of $408.42 and a 52-week high of $623.60. The firm has a market cap of $6.36 billion, a P/E ratio of 23.74, a PEG ratio of 2.17 and a beta of 0.44. The company’s 50-day simple moving average is $434.47 and its 200-day simple moving average is $444.39.

Chemed (NYSE:CHE) last announced its quarterly earnings results on Tuesday, October 28th. The company reported $5.27 earnings per share for the quarter, missing the consensus estimate of $5.39 by ($0.12). The business had revenue of $624.90 million during the quarter, compared to analysts’ expectations of $626.04 million. Chemed had a net margin of 11.02% and a return on equity of 25.89%. Chemed’s revenue for the quarter was up 3.1% on a year-over-year basis. During the same quarter in the prior year, the firm earned $5.64 EPS. Chemed has set its FY 2025 guidance at 22.000-22.300 EPS. On average, analysts anticipate that Chemed will post 21.43 earnings per share for the current fiscal year.

Chemed Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, December 5th. Shareholders of record on Monday, November 17th were issued a dividend of $0.60 per share. The ex-dividend date of this dividend was Monday, November 17th. This represents a $2.40 dividend on an annualized basis and a dividend yield of 0.5%. Chemed’s dividend payout ratio is presently 12.69%.

About Chemed

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.